BrilliantStrings Therapeutics, Inc.
Developer of a mechanotherapeutic platform based on complete human collagen for injectable treatment of connective tissue injuries. The company focuses on targeted, dense-collagen delivery formulations intended to support tendon and rotator cuff repair and is progressing toward scaled collagen production and Phase I clinical trials.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Injectable complete human collagen system for tendon repair
A dense, injectable collagen formulation designed to localize to tendon and rotator cuff injuries, deliver collagen to the injury site, and support repair through controlled release when administered under ultrasound guidance.
Injectable complete human collagen system for tendon repair
A dense, injectable collagen formulation designed to localize to tendon and rotator cuff injuries, deliver collagen to the injury site, and support repair through controlled release when administered under ultrasound guidance.
Expertise Areas
- Connective tissue therapeutics
- Injectable biomaterials
- Collagen biomanufacturing and scale-up
- Extracellular matrix biology and mechanochemistry
Key Technologies
- Complete human collagen formulations
- Liquid-crystal dense-phase delivery systems
- Controlled-release biomaterial formulations
- Ultrasound-guided injection techniques
News & Updates
Company statement indicating progress toward launching Phase I trials for their injectable collagen therapeutic.
Company statement indicating progress toward launching Phase I trials for their injectable collagen therapeutic.